Early Anti-Müllerian Hormone Levels in Adverse Pregnancy Outcomes in Women without Polycystic Ovary Syndrome
Ferhan Zengin Sadef, Berke Yesiltas, Burcu Dincgez, Gulten Ozgen, Tayfur Cift · Zeitschrift für Geburtshilfe und Neonatologie · 2026 · Heft 02 · S. 103-108
Bibliografische Angaben
Zusammenfassung
Abstract Objective Anti-Müllerian hormone (AMH) is commonly used in artificial reproductive treatments. Unfortunately, there is only limited data about AMH in adverse pregnancy outcomes. Here, we searched the role of first-trimester AMH to predict adverse pregnancy outcomes in women without polycystic ovary syndrome (PCOS). Methods A total of 240 pregnant women were enrolled in this prospective study. The inclusion criteria were being in the first trimester of pregnancy, having AMH levels measured, not having PCOS, and having had regular antenatal visits. Adverse outcomes were preeclampsia, gestational hypertens…
